0001415889-24-002065.txt : 20240131
0001415889-24-002065.hdr.sgml : 20240131
20240131162331
ACCESSION NUMBER: 0001415889-24-002065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240129
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vasquez Nicki
CENTRAL INDEX KEY: 0001877585
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 24583251
MAIL ADDRESS:
STREET 1: C/O SUTRO BIOPHARMA, INC.
STREET 2: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
form4-01312024_090124.xml
X0508
4
2024-01-29
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001877585
Vasquez Nicki
C/O SUTRO BIOPHARMA, INC.
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF PORT. STRAT & ALNCE OFCR
1
Common Stock
2024-01-29
4
S
0
12185
5
D
12803
D
Common Stock
2024-01-29
4
M
0
2500
0
A
15303
D
Common Stock
2024-01-29
4
F
0
1024
4.99
D
14279
D
Restricted Stock Unit (RSU)
2024-01-29
4
M
0
2500
0
D
2024-01-29
Common Stock
2500
0
D
This transaction was entered into pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 29, 2023.
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Nicki Vasquez
2024-01-31